Abbreviations
- AML:
-
Acute myeloid leukemia
- APM:
-
Antigen processing machinery
- β2-m:
-
β2-Microglobulin
- BrCa:
-
Breast cancer
- CP:
-
Cyclophosphamide
- CRC:
-
Colorectal cancer
- CSC:
-
Cancer stem cells
- CTL:
-
Cytotoxic T cells
- DC:
-
Dendritic cells
- DGK:
-
Diacylglycerol kinase
- ER:
-
Endoplasmic reticulum
- FSP:
-
Frame shift peptide
- HC:
-
Heavy chain
- HLA:
-
Human leukocyte antigen
- HER:
-
Human epidermal growth factor receptor
- IFN:
-
Interferon
- IL:
-
Interleukin
- ivt:
-
in vitro-transcribed
- MIC:
-
MHC class I derived related protein
- mAb:
-
Monoclonal antibody
- miR:
-
MicroRNA
- MMR:
-
Mismatch repair
- MUC-1:
-
Mucin-1
- MDSC:
-
Myeloid-derived suppressor cells
- NK:
-
Natural killer
- NKG2DL:
-
NKG2D ligand
- RCC:
-
Renal cell carcinoma
- shRNA:
-
Small hairpin RNA
- TAA:
-
Tumor-associated/specific antigens
- TAP:
-
Transporter associated with antigen processing
- TCR:
-
T cell receptor
- TFL:
-
Terasaki Foundation Laboratory
- TIL:
-
Tumor-infiltrating lymphocyte
- TIMO:
-
Tumor Immunology Meets Oncology
- Treg:
-
Regulatory T cell
- ULBP:
-
UL16-binding protein
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barthel, D., Seliger, B. “Tumor Immunology Meets Oncology (TIMO) VIII” from May 4 to 5, 2012, in Halle/Saale, Germany. Cancer Immunol Immunother 62, 197–202 (2013). https://doi.org/10.1007/s00262-012-1374-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-012-1374-6